CAHG and Diaceutics to launch Bioceutics

NEW YORK, USA: CAHG, a leading global professional healthcare communications company, and Diaceutics Ltd., specialists in personalized healthcare consulting, software and services, announced the formal launch of Bioceutics to develop communication strategies and educational and marketing campaigns specific to personalized healthcare.

Bioceutics' new business model integrates fragmented stakeholders by focusing on the ways in which a patient's journey from symptoms through diagnosis to treatment can be significantly altered when new tests are introduced along the way and when stakeholders receive enhanced education and communication.

By combining the insights and skills of Diaceutics and CAHG, Bioceutics has a clear vision and architecture for significantly evolving marketing and education in this area.

Bioceutics specializes in accelerating the potential of personalized healthcare that, despite its promising start, has not triggered the paradigm shift envisioned when the human genome was discovered ten years ago.

For diagnostics and pharmaceutical companies, Bioceutics accelerates the process with proprietary tools and services, such as the Bioceutics Leakage Index, People-Aided Design and Noninterventional "Real World" Studies.

Sanna Paakkonen, senior VP and MD, Bioceutics, said: "While some in the industry see diagnostics and patient stratification as adding complexity, we see diagnostics as a way to engage the patient and physician more deeply in each patient's treatment management. Personalized healthcare changes almost every aspect of the patient-physician engagement."